(Q46428506)
Statements
A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLL (English)
Thomas Decker
Katharina Goetze
Madlen Oelsner
Christian Peschel
14 August 2008
scientific article published on 14 August 2008